International Cannabis Weekly: 453

DO 10 DOCTORS REALLY PRESCRIBE HALF OF ENGLAND’S MEDICAL CANNABIS

The UK’s medical cannabis market has long been a locked box when it comes to reliable data. The fact that it is almost entirely private means that the data is largely proprietary, forcing us to piece together and model the market from snippets given to us by individual clinics or to parse large, unreliable data sets attained through Freedom of Information requests.

READ MORE  »

PUBLIC DATA NO LONGER ENOUGH TO UNDERSTAND THE GERMAN MEDICAL MARKET

READ MORE »

UKRAINE WAR VETERAN AND MS PATIENT RECEIVE FIRST MEDICAL CANNABIS PRESCRIPTIONS

READ MORE »

• Cannabis genetics explained: What F1, F2, BX and other breeding terms really mean.
• Cannabis-based medicine secures first European market approvals for chronic back pain treatment.
• Bedrocan develops high-THC concentrated cannabis flower for medical cannabis patients.
• Village Farms begins cultivation at Phase II cannabis production facility in the Netherlands.
• Czech proposal targets Europe’s most progressive hemp framework over intoxicating cannabinoid concerns.
• Seed Junky Genetics expands into Europe’s rapidly growing medical cannabis market.
• Irish medical cannabis CEO discusses innovation in a tightly controlled emerging sector.

LEARN MORE »

• The Women’s National Basketball Association has removed cannabis from its list of banned substances for players.
• Klutch Cannabis expands its Ohio footprint with a new dispensary in Columbus.
• Trulieve is making preparations to begin trading on the New York Stock Exchange as TRLV.
• Michigan wholesale cannabis tax revenues continue to generate significant state funding.
• California bill to allow cannabis dispensary drive-thru windows advances in Senate.
• Idaho legislative council approves ballot language limiting cannabis legalisation powers to lawmakers.
• Missouri dispensaries prepare for increased demand from international World Cup visitors.
• Virginia governor highlights productive negotiations on cannabis sales legalisation legislation.

• Emblem Cannabis moves to acquire Ayurcann assets and expand manufacturing capabilities.
• IM Cannabis files Form F-3 resale registration statement in the United States.
• Tilray launches premium medical cannabis brand ArX for patients in Germany.
• Canadian cannabis companies pursue growth through expansion of medical cannabis markets.
• Health Canada has recalled a cannabis product sold to consumers in the region of Alberta.
• Canadian governments earned $2.5 billion from adult-use cannabis sales in one fiscal year.

• Brazilian researchers say hemp fibres could extend the lifespan of recycled paper products.
• Medical education remains a key challenge for advancing cannabis treatment in Brazil.
• Cannabis takes centre stage as Brazilian university event explores health and research.
• Fiocruz hosts seminar focused on evidence and research in medical cannabis.

• New Caledonia has taken a historic step forward on its industrial hemp development.
• Chinese company agrees to fund Lebanon’s first public therapeutic cannabis research laboratory.
• NSW proposal is aiming to reform road rules affecting medicinal cannabis patients.
• Market slowdown is impacting Montu profits as costs approach the $300 million mark.
• Support grows for NSW medicinal cannabis driving reforms despite ongoing concerns.

• South Africa’s cannabis industry urges government to shift from consultation to implementation.
• Morocco has reached a new milestone with 140 approved medical cannabis products.
• Nigeria moves closer to legalising medical cannabis as reform efforts advance.